Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Sanofi pasteur licenses ChimeriVax-JE vaccine from Acambis

Feb. 16, 2007

RotaTeq prescribing information updated

Feb. 16, 2007

Positive preclinical results with a combined hepatitis A and E vaccine

Feb. 14, 2007

Novel cPLA2alpha inhibiting activity reported for the immunosuppressant agent FTY-720

Feb. 13, 2007

Pentavalent human-bovine rotavirus vaccine effective at end of shelf life

Feb. 9, 2007

New dosing recommendations for Rapamune in high immunologic risk patients

Feb. 7, 2007

Novel immunomodulatory agents disclosed in recent Kyorin and Novartis patents

Feb. 7, 2007

DelSite licenses technology to AriaVax for HIV vaccine

Feb. 6, 2007

End-of-phase II meeting for Pollinex Quattro Ragweed

Feb. 5, 2007

ShK5(L5) delays extravasation and reduces motility of effector memory T-cells

Feb. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...